EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Elevated Fracture Risks in Patients Using Inhaled Corticosteroids: A Korean Nationwide Study

Sung Hye Kong, Ae Jeong Jo, Chan Mi Park, Kyun Ik Park, Ji Eun Yun, Jung Hee Kim

Endocrinology and Metabolism · 28.02.2025 · 40 (1) · 82-92

DOI: 10.3803/enm.2024.1990 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology and Metabolism, erschienen am 28.02.2025. Verfasst von Sung Hye Kong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea. Hauptthemen laut MEDLINE: Adrenal Cortex Hormones, Osteoporotic Fractures, Asthma, Hip Fractures. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, National Evidence-based Healthcare Collaborating Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In this comprehensive retrospective nationwide cohort study, we examined the relationships between various asthma medications and bone health, utilizing data from the National Health Insurance Service database of South Korea.

Methods

From 2015 to 2019, the relevant dataset included 168,611 individuals aged 66 years, among whom 8,747 were diagnosed with asthma. We focused on a subset of 6,173 patients, all 66-year-old women. Participants were categorized into four groups: nonusers of asthma medication (n=2,868), leukotriene antagonist users (n=2,281), inhaled corticosteroid (ICS) users (n=517), and those using a combination of ICS and long-acting beta-agonist (ICS+LABA) medication (n=507). The primary outcomes measured were the incidences of major osteoporotic fractures and hip fractures during the follow-up period.

Results

Over 2.7 years of follow-up, 615 cases of major osteoporotic fractures and 96 cases of hip fractures were recorded. ICS users exhibited a heightened risk of both injuries, with hazard ratios of 1.38 (95% confidence interval [CI], 1.18 to 1.63; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal Cortex HormonesOsteoporotic FracturesAsthmaHip FracturesAnti-Asthmatic AgentsHumansFemaleAgedRepublic of KoreaRetrospective StudiesAdministration, InhalationIncidenceFollow-Up StudiesRisk FactorsAged, 80 and overMale

Stichwörter der Autor:innen

AsthmaFractureInhaled corticosteroidsOsteoporosis

Substanzen

Adrenal Cortex HormonesAnti-Asthmatic Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Data Science, Andong National University, Andong, Korea.
  • National Evidence-Based Healthcare Collaborating Agency (NECA), Seoul, Korea.
  • Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.

Förderung

  • National Research Foundation of Korea
  • National Evidence-based Healthcare Collaborating Agency

Zitieren

APA

Kong, S. H., Jo, A. J., Park, C. M., Park, K. I., Yun, J. E., & Kim, J. H. (2025). Elevated Fracture Risks in Patients Using Inhaled Corticosteroids: A Korean Nationwide Study. Endocrinology and Metabolism, 40(1), 82-92. https://doi.org/10.3803/enm.2024.1990

Vancouver

Kong SH, Jo AJ, Park CM, Park KI, Yun JE, Kim JH. Elevated Fracture Risks in Patients Using Inhaled Corticosteroids: A Korean Nationwide Study. Endocrinology and Metabolism. 2025;40(1):82-92. doi:10.3803/enm.2024.1990

BibTeX
@article{Kong2025,
  author = {Kong, Sung Hye and Jo, Ae Jeong and Park, Chan Mi and Park, Kyun Ik and Yun, Ji Eun and Kim, Jung Hee},
  title = {Elevated Fracture Risks in Patients Using Inhaled Corticosteroids: A Korean Nationwide Study},
  journal = {Endocrinology and Metabolism},
  year = {2025},
  volume = {40},
  number = {1},
  pages = {82--92},
  doi = {10.3803/enm.2024.1990}
}
Kostenlos starten →